These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells. Lanza F, Castagnari B, Rigolin G, Moretti S, Latorraca A, Ferrari L, Bardi A, Castoldi G. Leukemia; 1997 Oct; 11(10):1700-10. PubMed ID: 9324292 [Abstract] [Full Text] [Related]
4. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G. Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174 [Abstract] [Full Text] [Related]
5. Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis. DiGiuseppe JA, LeBeau P, Augenbraun J, Borowitz MJ. Am J Clin Pathol; 1996 Sep; 106(3):345-51. PubMed ID: 8816592 [Abstract] [Full Text] [Related]
7. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia. van Stijn A, van der Pol MA, Kok A, Bontje PM, Roemen GM, Beelen RH, Ossenkoppele GJ, Schuurhuis GJ. Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269 [Abstract] [Full Text] [Related]
8. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Andreeff M, Jiang S, Zhang X, Konopleva M, Estrov Z, Snell VE, Xie Z, Okcu MF, Sanchez-Williams G, Dong J, Estey EH, Champlin RC, Kornblau SM, Reed JC, Zhao S. Leukemia; 1999 Nov; 13(11):1881-92. PubMed ID: 10557066 [Abstract] [Full Text] [Related]
15. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome]. Zhang Z, Xie J. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412 [Abstract] [Full Text] [Related]
17. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Suárez L, Vidriales B, García-Laraña J, López A, Martínez R, Martín-Reina V, Tormo M, González-San Miguel JD, Lavilla E, García-Boyero R, Orfao A, San Miguel JF, PETHEMA Cooperative Group. Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321 [Abstract] [Full Text] [Related]
18. Blast maturity and CD34 expression determine the effects of the differentiating agents KH1060 and 9-cis-retinoic acid on the differentiation and clonogenicity of non-M3 acute myeloid leukaemia cells. Pallis M, Turzanski J, Russell NH. Leukemia; 1998 Nov; 12(11):1741-8. PubMed ID: 9823949 [Abstract] [Full Text] [Related]
19. Bcl-x(L) is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression. Pallis M, Zhu YM, Russell NH. Leukemia; 1997 Jul; 11(7):945-9. PubMed ID: 9204973 [Abstract] [Full Text] [Related]
20. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Lanza F, Rigolin GM, Moretti S, Latorraca A, Castoldi G. Leuk Lymphoma; 1994 Jul; 13 Suppl 1():81-5. PubMed ID: 7521238 [Abstract] [Full Text] [Related] Page: [Next] [New Search]